Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Extensive Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07583550
What this trial is testing

Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy, and Then Sequential Maintenance Therapy With Adebrelimab for Extensive-stage Small Cell Lung Cancer

Who this might be right for
LungRadiotherapy
Jiangmen Central Hospital 43
Testing effectiveness (Phase 2)Study completedNCT03913455
What this trial is testing

Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerExtensive-stage Small Cell Lung Cancer
Shadia Jalal, MD 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05765825
What this trial is testing

Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Sichuan University 61
Testing effectiveness (Phase 2)Study completedNCT00003943
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

Who this might be right for
Carcinoma of Unknown PrimaryLung Cancer
Fox Chase Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT01025284
What this trial is testing

Participants With Small-Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT05384015
What this trial is testing

Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Fundación GECP 46
Testing effectiveness (Phase 2)Looking for participantsNCT05882058
What this trial is testing

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Who this might be right for
Small Cell Lung CarcinomaNeuroendocrine NeoplasmsExtra-pulmonary Neuroendocrine Carcinoma
Boehringer Ingelheim 204
Testing effectiveness (Phase 2)Study completedNCT01262560
What this trial is testing

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Who this might be right for
DysphagiaLung CancerPain+1 more
Radiation Therapy Oncology Group 163
Large-scale testing (Phase 3)UnknownNCT00003696
What this trial is testing

Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Commissie Voor Klinisch Toegepast Onderzoek 250
Testing effectiveness (Phase 2)UnknownNCT04901754
What this trial is testing

Camrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Henan Cancer Hospital 38
Testing effectiveness (Phase 2)Looking for participantsNCT05623319
What this trial is testing

Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
SCLC,Extensive Stage
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 60
Testing effectiveness (Phase 2)UnknownNCT00014547
What this trial is testing

BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Lung Cancer
Theradex
Not applicableEnded earlyNCT00896467
What this trial is testing

Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy

Who this might be right for
Anal CancerAnxiety DisorderBreast Cancer+9 more
Centre Oscar Lambret 200
Large-scale testing (Phase 3)Active Not RecruitingNCT06211036
What this trial is testing

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

Who this might be right for
Extensive-Stage Small-Cell Lung CancerSmall-Cell Lung Cancer
Amgen 563
Large-scale testing (Phase 3)Study completedNCT00003299
What this trial is testing

Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 587
Early research (Phase 1)UnknownNCT03971214
What this trial is testing

PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung CancerRadiotherapyImmunotherapy
Chinese Academy of Medical Sciences 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04472949
What this trial is testing

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

Who this might be right for
Small Cell Lung CancerLung Cancer
Swiss Cancer Institute 46
Testing effectiveness (Phase 2)UnknownNCT03755115
What this trial is testing

SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Henan Cancer Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06497530
What this trial is testing

Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease 30
Not applicableEnded earlyNCT02011087
What this trial is testing

Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line Chemotherapy

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Wake Forest University Health Sciences 1
Next Page